Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Royalty Pharma (RPRX – Research Report), ...

Management emphasized three strategic priorities for 2025: driving mid-single-digit revenue growth, managing costs with a target of 86% for cost of services and 8.5%-9.5% for SG&A, and optimizing cash ...